TIDMPEBI

RNS Number : 5331F

Port Erin Biopharma Investments Ltd

18 June 2012

Port Erin Biopharma Investments Limited

("Port Erin" or the "Company")

Director's Dealing

Port Erin, the AIM listed company focused on investing in the biotechnology and biopharmaceutical sectors, was informed that Galloway Limited purchased 500,000 Ordinary Shares at a price of 7 pence per share on 15 June 2012.

Galloway Limited is wholly owned by a trust in which Jim Mellon, Chairman of the Company, has a life tenancy. Denham Eke, a Director of the Company, is a director of Galloway Limited.

Following this transaction, the total Ordinary Shares in which Jim Mellon has a beneficial interest is 3,941,000, representing 11.8% of the issued ordinary share capital of the Company.

Enquiries:

 
 
 Port Erin Biopharma Investments 
  Limited 
 Denham Eke                            (+44) 1624 639396 
 
 Libertas Capital Corporate Finance 
  Limited 
 Sandy Jamieson                        (+44) 20 7569 9650 
 
 Rivington Street Corporate Finance 
  Limited 
 John Levinson                         (+44) 20 7562 3350

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSKDLBFLQFLBBV

Agronomics (LSE:ANIC)
Historical Stock Chart
From Aug 2024 to Sep 2024 Click Here for more Agronomics Charts.
Agronomics (LSE:ANIC)
Historical Stock Chart
From Sep 2023 to Sep 2024 Click Here for more Agronomics Charts.